| [1] |
Mvundura M, Grosse SD, Hampel H, et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer [J]. Genet Med, 2010, 12(2): 93-104.
|
| [2] |
Musulen E, Sanz C, Munoz-Marmol AM, et al. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome [J]. Hum Pathol, 2014, 45(7): 1388-1396.
|
| [3] |
Kastrinos F, Uno H, Ukaegbu C, et al. Development and validation of the PREMM5 model for comprehensive risk assessment of Lynch syndrome [J]. J Clin Oncol, 2017, 35(19): 2165-2172.
|
| [4] |
Hampel H. NCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancer [J]. J Natl Compr Canc Netw, 2014, 12(5 Suppl): 829-831.
|
| [5] |
Syngal S, Brand RE, Church JM, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes [J]. Am J Gastroenterol, 2015, 110(2): 223-262.
|
| [6] |
Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American society of clinical oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European society for medical oncology clinical practice guidelines [J]. J Clin Oncol, 2015, 33(2): 209-217.
|
| [7] |
Evaluation of Genomic Applications in Practice and Prevention Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives [J]. Genet Med, 2009, 11(1): 35-41.
|
| [8] |
Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer [J]. Am J Gastroenterol, 2014, 109(8): 1159-1179.
|
| [9] |
Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts [J]. Gut, 2013, 62(6): 812-823.
|
| [10] |
Bartley AN, Hamilton SR, Alsabeh R, et al. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum [J]. Arch Pathol Lab Med, 2014, 138(2): 166-170.
|
| [11] |
Markow M, Chen W, Frankel WL. Immunohistochemical pitfalls: Common mistakes in the evaluation of Lynch syndrome [J]. Surg Pathol Clin, 2017, 10(4): 977-1007.
|
| [12] |
Mihaylova VT, Bindra RS, Yuan J, et al. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells [J]. Mol Cell Biol, 2003, 23(9): 3265-3273.
|
| [13] |
Mills AM, Longacre TA. Lynch syndrome: Female genital tract cancer diagnosis and screening [J]. Surg Pathol Clin, 2016, 9(2): 201-214.
|
| [14] |
Rodriguez-Soler M, Perez-Carbonell L, Guarinos C, et al. Risk of cancer in cases of suspected lynch syndrome without germline mutation [J]. Gastroenterology, 2013, 144(5): 926-932.
|
| [15] |
Pai RK, Pai RK. A practical approach to the evaluation of gastrointestinal tract carcinomas for Lynch syndrome [J]. Am J Surg Pathol, 2016, 40(4): e17-34.
|
| [16] |
Geurts-Giele WR, Leenen CH, Dubbink HJ, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers [J]. J Pathol, 2014, 234(4): 548-559.
|
| [17] |
Haraldsdottir S, Hampel H, Tomsic J, et al. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations [J]. Gastroenterology, 2014, 147(6): 1308-1316 e1301.
|
| [18] |
Morak M, Heidenreich B, Keller G, et al. Biallelic MUTYH mutations can mimic Lynch syndrome [J]. Eur J Hum Genet, 2014, 22(11): 1334-1337.
|
| [19] |
Sourrouille I, Coulet F, Lefevre JH, et al. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors [J]. Fam Cancer, 2013, 12(1): 27-33.
|
| [20] |
Ward RL, Dobbins T, Lindor NM, et al. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry [J]. Genet Med, 2013, 15(1): 25-35.
|
| [21] |
Sekine S, Ogawa R, Saito S, et al. Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM-MSH2 fusion [J]. Histopathology, 2017, 70(4): 664-669.
|
| [22] |
Graham RP, Kerr SE, Butz ML, et al. Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas [J]. Am J Surg Pathol, 2015, 39(10): 1370-1376.
|
| [23] |
Kumarasinghe AP, de Boer B, Bateman AC, et al. DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material [J]. Pathology, 2010, 42(5): 414-420.
|
| [24] |
Bao F, Panarelli NC, Rennert H, et al. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma [J]. Am J Surg Pathol, 2010, 34(12): 1798-1804.
|
| [25] |
Radu OM, Nikiforova MN, Farkas LM, et al. Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: nucleolar MSH6 staining and impact of prior chemoradiation therapy [J]. Hum Pathol, 2011, 42(9): 1247-1258.
|
| [26] |
Vilkin A, Halpern M, Morgenstern S, et al. How reliable is immunohistochemical staining for DNA mismatch repair proteins performed after neoadjuvant chemoradiation? [J]. Hum Pathol, 2014, 45(10): 2029-2036.
|
| [27] |
Hagen CE, Lefferts J, Hornick JL, et al. ″Null pattern″ of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation [J]. Am J Surg Pathol, 2011, 35(12): 1902-1905.
|
| [28] |
Shia J, Zhang L, Shike M, et al. Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency [J]. Mod Pathol, 2013, 26(1): 131-138.
|
| [29] |
Halvarsson B, Lindblom A, Johansson L, et al. Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer [J]. Mod Pathol, 2005, 18(8): 1095-1101.
|
| [30] |
Kalady MF, Kravochuck SE, Heald B, et al. Defining the adenoma burden in lynch syndrome [J]. Dis Colon Rectum, 2015, 58(4): 388-392.
|
| [31] |
Walsh MD, Buchanan DD, Pearson SA, et al. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry [J]. Mod Pathol, 2012, 25(5): 722-730.
|
| [32] |
Bae JM, Kim JH, Kang GH. Molecular subtypes of colorectal cancer and their clinicopathologic features, with an emphasis on the serrated neoplasia pathway [J]. Arch Pathol Lab Med, 2016, 140(5): 406-412.
|
| [33] |
Bodo S, Colas C, Buhard O, et al. Diagnosis of constitutional mismatch repair-Deficiency syndrome based on microsatellite instability and lymphocyte tolerance to methylating agents [J]. Gastroenterology, 2015, 149(4): 1017-1029.
|